Joe Turner, former Chief Financial Officer at Myogen (now Gilead (NASDAQ: GILD)), has joined the privately held Los Angeles-based Kythera Biopharmaceuticals Board of Directors. Not only is Joe an incredibly talented executive and individual but most selfishly he too has had a profound impact upon my personal life and professional development, and for that I [...]